ANI Pharmaceuticals Q1 2026 EPS Beats Estimates; Revenue Up 20%
AlphaStreet Newsdesk powered by AlphaStreet Intelligence Related Coverage Transcript ANI Pharmaceuticals, Inc (ANIP) Q1 2026 Earnings Call Transcript May 8, ...
Monday, May 25, 2026
Tag: Pharmaceuticals
Indivior Pharmaceuticals Q1 2026 Deep Dive: EPS Beats by 43.3%, Revenue Up 19%
AlphaStreet Newsdesk powered by AlphaStreet Intelligence Related Coverage INDV|EPS $0.96 vs $0.67 est (+43.3%)|Rev $317.0M|Net Income $89.0M Stock $36.78 (+7.7%) ...
Verrica Pharmaceuticals inc (VRCA) Q4 2025 Earnings Results
“ Verrica narrows Q4 loss 72% year-over-year to -$0.51 per share as revenue surges 1,383% to $5.1M, though sequential revenue ...
Teva Pharmaceuticals – TEVA: Abschied vom Generika-Geschäft! Was nun?
Strategische Neuausrichtung! Pullback-Setup bei der Teva-Aktie! Kommt der Bounce nach 7 roten Kerzen? Quartalszahlen erst im Mai! Teva Pharmaceuticals (TEVA) ...
Regeneron Pharmaceuticals: Nach erfolgreichem Ausbruch – Pullback-Szenario bietet attraktives Setup!
Chance nach charttechnischem Befreiungsschlag! Rückblick Seit Ende Oktober befindet sich die Regeneron-Aktie in einem stabilen Aufwärtstrend. Nach einem scharfen Rücksetzer ...
Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!
Zilebesiran in Phase 3! Pharma-Aktie Alnylam Pharmaceuticals (ALNY) testet 20er-EMA mit Rücksetzer vom Allzeithoch! JETZT einsteigen? Kursziel nach Measured Move ...
Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings
ClearBridge Investments, an investment management company, released its “ClearBridge All Cap Growth Strategy” second-quarter 2025 investor letter. A copy of ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.